PT Merck Tbk Indonesia
Founded in 1970, PT Merck Tbk went public in 1981, and was one of the first companies registered on the Indonesia Stock Exchange. The majority of the shares are held by the Merck Group, headquartered in Germany the oldest pharmaceutical and chemical companies in the world. For further information on our headquarter, you can visit www.merck.de
PT Merck Tbk. is a leading multinational company in the pharmaceutical and chemical business in Indonesia.
- In pharmaceutical, we manufacture and markets well-known pharmaceutical brands such as Neurobion®, Sangobion® and Glucophage® in a cGMP certified facility.
- In Chemical business, Merck markets a whole range of laboratory reagents, pigments and other specialty chemicals.
Our comprehensive distribution network ensures product availability throughout the archipelago. Please contact us to help locate the nearest distributor to you.
| Facts & Figures | |
| President Director | Markus Bamberger |
| Number of employees | 800 |
| Major products
Merck Serono (prescription drugs) | Cardiovascular line (e.g. Concor®), Metabolic line (e.g. Glucophage®), Neurology line (e.g. Neurobion 5000®), Women Health (e.g. Hemobion®), Oncology (Erbitux®). |
| Major products
Consumer Health Care (self-medication products) | Sangobion®, Neurobion, Becombion®, Bion 3®, Seven Seas Orange Syrup® and others. |
| Major products – Chemicals |
|
